NDP Antibody

Shipped with Ice Packs
In Stock

Description

Structure and Function of NDP Antibody

NDP antibodies are polyclonal or monoclonal reagents developed to bind epitopes on the norrin protein. Key characteristics include:

Antibody SourceReactivityApplicationsImmunogenConjugation
Rabbit Polyclonal (Abcam) MouseWBHuman full-length recombinant proteinNone
Rabbit Polyclonal (Boster) HumanWB, ICCSynthetic peptide (N-terminal 18 aa)None
Rabbit Polyclonal (Bio-Techne) MouseIHC, WBSynthetic peptide (central region)DyLight 650
Goat Polyclonal (R&D Systems) Human (50% cross-reactivity with mouse)ELISA, WBHuman norrinNone

Key Features:

  • Epitope Specificity: Antibodies target regions spanning the full-length protein (Abcam ), N-terminal domains (Boster ), or central regions (Bio-Techne ).

  • Applications: Primarily used in Western blot (WB), immunocytochemistry (ICC), and immunohistochemistry (IHC) to analyze norrin expression in tissues .

  • Sensitivity: Western blot detection limits vary; R&D Systems’ AF3014 antibody detects human norrin in lysates .

Research Applications and Clinical Relevance

NDP antibodies are pivotal in studying norrin’s role in developmental biology and disease.

Gene Therapy and Disease Modeling

In a landmark study, AAV9-mediated NDP gene therapy restored retinal and cochlear function in Ndp-KO mice . Antibodies were used to:

  • Confirm Transgene Expression: qRT-PCR and WB detected human NDP mRNA and EGFP-P2A-NDP fusion protein in treated retinas and cochleae .

  • Assess Therapeutic Efficacy: Neonatal treatment preserved retinal vascularization and auditory function, while juvenile/adult treatment partially rescued cochlear pathology .

Wnt Signaling Pathway Analysis

Norrin activates β-catenin signaling via FZD4/LRP5 receptors . Antibodies enable:

  • TopFlash Reporter Assays: Confirming recombinant norrin’s ability to activate canonical Wnt pathways .

  • Surrogate Antibody Studies: A FZD4:LRP5 agonist antibody (F4L5.13) mimics norrin’s effects on endothelial barrier function, highlighting cross-talk between Wnt-independent and -dependent pathways .

Diagnostic Potential

NDP antibodies may aid in:

  • Norrie Disease Diagnosis: Detecting norrin protein levels in patient samples to confirm NDP mutations .

  • Monitoring Gene Therapy: Tracking transgene expression post-treatment in clinical trials .

Gene Therapy Outcomes in Ndp-KO Mice

Treatment StageRetinal OutcomesCochlear Outcomes
Neonatal (P2) Normal vascularization; restored electroretinogramsPrevention of hair cell death; normalized ABR thresholds
Juvenile (P21) Restored blood vessel barrier proteinsPartial preservation of sensory cells
Young Adult (P30) Limited vascular recoveryMitigated hearing loss progression

Antibody Performance in Assays

AntibodyWB SensitivitySpecies Cross-Reactivity
Abcam (ab185715) Detects ~15.5 kDa monomerMouse-specific
Boster (A01045) Detects 68 kDa isoformsHuman-specific
R&D Systems (AF3014) Detects human norrin50% cross-reactivity with mouse

Table 1: Antibody Reactivity and Applications

VendorAntibody TypeTarget SpeciesApplicationsImmunogen
Abcam Rabbit PolyclonalMouseWBFull-length human NDP
Boster Rabbit PolyclonalHumanWB, ICCN-terminal peptide
Bio-Techne Rabbit PolyclonalMouseIHC, WBCentral peptide
R&D Systems Goat PolyclonalHumanELISA, WBHuman norrin

Table 2: Gene Therapy Efficacy in Ndp-KO Mice

EndpointNeonatal (P2)Juvenile (P21)Young Adult (P30)
Retinal VascularizationFully restoredPartial recoveryLimited improvement
Cochlear Hair CellsComplete preservationPartial survivalReduced progression
Hearing FunctionNormalized ABRImproved thresholdsStabilized loss

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your order. Delivery time may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery timeframes.
Synonyms
EVR2 antibody; Exudative vitreoretinopathy 2 (X linked) antibody; FEVR antibody; ND antibody; NDP antibody; NDP_HUMAN antibody; Norrie disease (pseudoglioma) antibody; Norrie disease protein antibody; Norrin antibody; Norrin precursor antibody; X linked exudative vitreoretinopathy 2 protein antibody; X-linked exudative vitreoretinopathy 2 protein antibody
Target Names
NDP
Uniprot No.

Target Background

Function
Norrin (NDP) is a potent activator of the canonical Wnt signaling pathway through the FZD4 and LRP5 coreceptors. It plays a crucial role in retinal vascularization by acting as a ligand for FZD4, triggering a signaling cascade that stabilizes beta-catenin (CTNNB1) and activates LEF/TCF-mediated transcriptional programs. Norrin collaborates with TSPAN12 to activate FZD4 independently of Wnt-dependent activation, indicating the existence of a Wnt-independent signaling pathway that also promotes beta-catenin (CTNNB1) accumulation. Additionally, Norrin may participate in a pathway regulating neural cell differentiation and proliferation, potentially playing a role in neuroectodermal cell-cell interaction.
Gene References Into Functions
  1. NDP acts as a potent trigger for FZD4 ubiquitination, leading to internalization of the NDP receptor complex into the endo-lysosomal compartment. Inhibition of ubiquitinated cargo transport through the multivesicular body (MVB) pathway, utilizing a dominant negative ESCRT (endosomal sorting complexes required for transport) component VPS4 EQ, significantly impairs NDP/FZD4 signaling in vitro. PMID: 28675177
  2. A novel mutation was identified in the NDP gene within the affected males of a family. As this mutation was absent in normal male family members, it is strongly implicated as the genetic cause of the disease. PMID: 28922694
  3. Genetic analysis of the NDP gene revealed a novel frameshift mutation c.222_c223insCG in p1, leading to a premature stop codon and the production of an aberrant norrin protein. In P2, the clinical presentation included high myopia with astigmatism, unilateral fibrous bands, and retinal detachment. Genetic testing revealed a known point mutation c.362G>A, leading to amino acid alteration and improper protein folding. Conclus PMID: 30088388
  4. The patient exhibiting a complete NDP gene deletion did not display any noticeable extraocular defects (like mental retardation or sensorineural hearing loss) during the first decade of life, a significant finding. This study emphasizes the importance of genetic testing to eliminate ambiguities in clinical diagnosis, detect carrier status, and support patient and family members. PMID: 28602015
  5. Screening of candidate genes, specifically NDP, FZD4, and TSPAN12, led to the identification of six major coding region variants in 36 ROP probands. PMID: 28982955
  6. The c.314C>A mutation in the NDP gene represents a novel finding and broadens the genetic spectrum of Norrie disease. PMID: 29133643
  7. Probands with LRP5 or NDP mutations were primarily classified into groups III and IV, while TSPAN12 mutations were predominantly observed in probands with groups IV and V FEVR. PMID: 29181528
  8. The mutation c.310A>C (p.Lys104Gln) in exon 3 of NDP is associated with familial exudative vitreoretinopathy in the studied family. PMID: 27720678
  9. Among the detected mutations, LRP5 accounted for the largest proportion, with a mean mutation rate of 16.1% (5/31, 16.1%), followed by NDP (3/31, 9.7%), FZD4 (2/31, 6.5%), TSPAN12 (1/31, 3.2%), and KIF11 (1/31, 3.2%). All novel changes were predicted to be pathogenic based on a series of bioinformatics analyses. PMID: 28494495
  10. This study reports a novel missense NDP mutation in a familial case of Norrie disease within a Chinese family. PMID: 26547627
  11. A hemizygous pathogenic variant in NDP, c.293 C>T, p.(Pro98Leu), was identified in two brothers presenting with isolated bilateral microphthalmia and sclerocornea. PMID: 26130484
  12. This study provides the first evidence demonstrating the involvement of NDP among patients with Indian familial exudative vitreoretinopathy (FEVR), further expanding the known mutation spectrum. PMID: 27217716
  13. Structural, biophysical, and cellular data map Fz4 and putative Lrp5/6 binding sites to distinct patches on Norrin, revealing a GAG binding site spanning Norrin and the Fz4 cysteine-rich domain. PMID: 26158506
  14. Genetic evaluation of a case of bilateral leukocoria and asymmetric microphthalmia revealed a previously undescribed mutation in the Norrie disease protein gene. PMID: 26459204
  15. Norrin may play a role in the regulation of angiogenesis. PMID: 25005225
  16. This study identified a novel c.277T>C missense mutation causing the substitution of a hydrophobic cysteine to a hydrophilic arginine [p.(Cys93Arg)] in patients with Norrie disease. PMID: 24801666
  17. Norrie disease was diagnosed in three patients from a Japanese family through clinical examination and confirmed by genetic analysis. PMID: 25023092
  18. Norrin induces the formation of a ternary complex with Fz4 and Lrp5/6 by binding to their respective extracellular domains. PMID: 24186977
  19. This report details a missense mutation, p.Arg41Ser, in NDP causing Norrie disease in an Indian family. PMID: 22674248
  20. Norrin is a multifunctional protein that acts as a ligand for the LGR4 receptor. PMID: 23444378
  21. NDP mutations are a common cause of Norrie disease but may be a rare cause of familial exudative vitreoretinopathy (FEVR) in the Chinese population. PMID: 22563645
  22. In cases of dysplastic retinas with bilateral multiple unclear pseudotumorous lesions, cytology appears to be a valuable tool for rapid differentiation between patients with Norrie's syndrome and those with retinoblastoma or lymphoma. PMID: 21159148
  23. Norrin exhibits neuroprotective properties for retinal neurons independent of its role in retinal capillary growth. PMID: 22183393
  24. Mutation screening of the NDP gene identified a novel nonsense mutation, c.343C>T. PMID: 21179243
  25. A novel Norrin missense mutation, p.Arg41Thr, was identified in two apparently unrelated families with Norrie disease. PMID: 20491809
  26. Studies report 21 novel variants for FZD4, LRP5, and NDP. PMID: 20340138
  27. A single base-pair deletion, c.268delC, was identified in the NDP gene, causing a severe Norrie disease phenotype in the male proband and peripheral retinal vascular abnormalities with dragged maculae similar to those observed in other cases. PMID: 20227630
  28. Norrin possesses pronounced neuroprotective properties on retinal neurons. Its effects involve activation of Wnt/beta-catenin signaling and subsequent induction of neurotrophic growth factors in Muller cells. PMID: 20427659
  29. Norrin is a potent factor that induces angiogenesis in microvascular and endothelial cells following oxygen-induced retinal vessel loss. PMID: 20053900
  30. De novo mutations in the 5' regulatory region have been implicated in retinopathy of prematurity. PMID: 11748312
  31. Data demonstrate a strong association between the AA genotype of the C597A Norrie disease gene polymorphism and progression of retinopathy of prematurity. PMID: 12145535
  32. No Norrie Disease (ND) gene mutations were detected in this study. PMID: 12546446
  33. DNA sequencing revealed a novel missense mutation (703G>T), which significantly alters the predicted protein structure. PMID: 15609522
  34. This study reports two novel mutations in the NDP gene in Mexican patients and proposes that GeneScan is a viable method for establishing ND carrier status. PMID: 15799735
  35. NDP polymorphisms may contribute to the pathogenesis of retinopathy of prematurity but do not appear to be a major causative factor. PMID: 16052165
  36. This study discusses Wnt proteins and a novel Frizzled ligand, Norrin, in physiological and pathological angiogenesis. PMID: 16714476
  37. Genetic testing of NDP was found to be helpful in confirming the diagnosis of X-linked FEVR (familial exudative vitreoretinopathy) in male patients, particularly when limited family history was available. PMID: 17050281
  38. Norrin binds to the Frizzled4 cysteine-rich domain (CRD) and does not detectably bind to 14 other mammalian Frizzled and secreted Frizzled-related protein CRDs. PMID: 17158104
  39. Patients exhibiting severe retinal dysgenesis should be suspected of carrying a mutation that disrupts the cysteine-knot motif in the NDP gene. PMID: 17296899
  40. Observations indicate that mutations in the NDP gene can cause ND (Norrie disease) and 6% of FEVR (familial exudative vitreoretinopathy) cases in the Japanese population. PMID: 17325173
  41. A novel missense mutation at position c.134T > A, resulting in an amino acid change at codon V45E, was identified in Norrie disease with neurological disorder and infantile spasms. PMID: 17334993
  42. Norrin mutants demonstrated variable effects on signal transduction, and no clear correlation with clinical phenotypes was observed. PMID: 17955262
  43. This study correlated ophthalmic examination with carrier status for asymptomatic females from a family known to harbor a severe ND gene mutation (C95F). PMID: 18387409
  44. This study reports a novel mutation in the NDP gene in a patient whose presentation demonstrates the phenotypic heterogeneity of NDP-related disorders. PMID: 19373682

Show More

Hide All

Database Links

HGNC: 7678

OMIM: 300658

KEGG: hsa:4693

STRING: 9606.ENSP00000367301

UniGene: Hs.522615

Involvement In Disease
Norrie disease (ND); Vitreoretinopathy, exudative 2 (EVR2)
Subcellular Location
Secreted.
Tissue Specificity
Expressed in the outer nuclear, inner nuclear and ganglion cell layers of the retina, and in fetal and adult brain.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.